20.35
0.29 (1.47%)
| Previous Close | 20.05 |
| Open | 20.11 |
| Volume | 200,059 |
| Avg. Volume (3M) | 845,762 |
| Market Cap | 1,218,959,872 |
| Price / Earnings (Forward) | 344.83 |
| Price / Sales | 2.68 |
| Price / Book | 4.13 |
| 52 Weeks Range | |
| Earnings Date | 8 Dec 2025 |
| Profit Margin | -9.83% |
| Operating Margin (TTM) | -46.68% |
| Diluted EPS (TTM) | -0.740 |
| Quarterly Revenue Growth (YOY) | 45.70% |
| Total Debt/Equity (MRQ) | 2.60% |
| Current Ratio (MRQ) | 1.95 |
| Operating Cash Flow (TTM) | 47.95 M |
| Levered Free Cash Flow (TTM) | 35.26 M |
| Return on Assets (TTM) | -5.98% |
| Return on Equity (TTM) | -15.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | Phreesia, Inc. | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.25 |
|
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 4.32% |
| % Held by Institutions | 95.90% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 38.00 (Canaccord Genuity, 86.78%) | Buy |
| Median | 34.00 (67.12%) | |
| Low | 32.00 (BMO Capital, 57.29%) | Buy |
| 32.00 (Keybanc, 57.29%) | Buy | |
| 32.00 (Stephens & Co., 57.29%) | Buy | |
| Average | 34.00 (67.12%) | |
| Total | 9 Buy | |
| Avg. Price @ Call | 26.92 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BMO Capital | 13 Nov 2025 | 32.00 (57.29%) | Buy | 22.53 |
| Keybanc | 08 Oct 2025 | 32.00 (57.29%) | Buy | 23.25 |
| JMP Securities | 08 Sep 2025 | 34.00 (67.12%) | Buy | 26.78 |
| Truist Securities | 08 Sep 2025 | 36.00 (76.95%) | Buy | 26.78 |
| Canaccord Genuity | 05 Sep 2025 | 38.00 (86.78%) | Buy | 28.13 |
| DA Davidson | 05 Sep 2025 | 33.00 (62.20%) | Buy | 28.13 |
| Needham | 05 Sep 2025 | 35.00 (72.03%) | Buy | 28.13 |
| Piper Sandler | 05 Sep 2025 | 34.00 (67.12%) | Buy | 28.13 |
| Stephens & Co. | 03 Sep 2025 | 32.00 (57.29%) | Buy | 30.44 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 19 Nov 2025 | Announcement | Phreesia Named to the 2025 Deloitte Technology Fast 500™ |
| 03 Nov 2025 | Announcement | Phreesia Sets Release Date for Fiscal Third Quarter 2026 Results |
| 08 Oct 2025 | Announcement | Phreesia Named to the 2025 Capterra Shortlists for Appointment Reminders and Appointment Scheduling |
| 30 Sep 2025 | Announcement | Phreesia Named to TIME’s 2025 List of the World’s Top HealthTech Companies |
| 16 Sep 2025 | Announcement | Becker’s Names Phreesia’s Sara DiNardo as one of 2025’s Rising Stars of Healthcare |
| 04 Sep 2025 | Announcement | Phreesia Announces Second Quarter Fiscal 2026 Results |
| 04 Sep 2025 | Announcement | Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions |
| 02 Sep 2025 | Announcement | Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare |
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 May 2013 | 07 Feb 2013 | 17 Jun 2013 | 0.5625 Cash |
| 27 Feb 2013 | 06 Feb 2013 | 15 Mar 2013 | 0.5625 Cash |
| 28 Nov 2012 | - | 15 Dec 2012 | 0.5625 Cash |
| 29 Aug 2012 | - | 15 Sep 2012 | 0.5625 Cash |
| 30 May 2012 | - | 15 Jun 2012 | 0.5625 Cash |
| 28 Feb 2012 | - | 15 Mar 2012 | 0.5625 Cash |
| 30 Aug 2011 | - | 15 Sep 2011 | 0.5625 Cash |
| 27 May 2011 | - | 15 Jun 2011 | 0.5625 Cash |
| 25 Feb 2011 | - | 15 Mar 2011 | 0.5625 Cash |
| 29 Nov 2010 | - | 15 Dec 2010 | 0.5625 Cash |
| 30 Aug 2010 | - | 15 Sep 2010 | 0.5625 Cash |
| 27 May 2010 | - | 15 Jun 2010 | 0.5625 Cash |
| 25 Feb 2010 | - | 15 Mar 2010 | 0.5625 Cash |
| 27 Nov 2009 | - | 15 Dec 2009 | 0.5625 Cash |
| 28 Aug 2009 | - | 15 Sep 2009 | 0.5625 Cash |
| 28 May 2009 | - | 15 Jun 2009 | 0.5625 Cash |
| 25 Feb 2009 | - | 16 Mar 2009 | 0.5625 Cash |
| 26 Nov 2008 | - | 15 Dec 2008 | 0.5625 Cash |
| 27 Aug 2008 | - | 15 Sep 2008 | 0.46875 Cash |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |